Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme04:17

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme

1.1K
In this article, we detail methods to characterize an enzyme's ability to retain function when incubated at 37 °C in human serum, a pharmacological property referred to as its serum stability. This ability may be a key factor in predicting an enzyme's pharmacokinetic profile and its suitability for therapeutic...
1.1K
Feedback Inhibition00:46

Feedback Inhibition

56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells05:01

Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells

1.7K
This video explains a quantitative reverse phase high-performance liquid chromatography (RP-HPLC) method to measure metabolism of adenosine and associated purines generated by consumption of AMP in extracellular environment of leukemic cancer cells. The protocol describes a sensitive, specific, reliable and reproducible RP-HPLC assay developed and validated for the quantification of extracellular purine nucleotides and nucleosides produced by purified chronic lymphocytic leukemia (CLL) cells...
1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

4.2K
Coronary vasomotion disorders represent frequent functional causes of angina in patients with unobstructed coronaries. The underlying mechanism of angina (endotype) in these patients can be determined by a comprehensive invasive diagnostic procedure based on acetylcholine provocation testing followed by Doppler-derived assessment of the coronary flow reserve and microvascular...
4.2K
Enzyme Inhibition01:30

Enzyme Inhibition

91.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of ultraviolet, gamma- and X-ray irradiation on the growth, antibacterial activity and radio-protective of Lactobacillus rhamnosus.

Letters in applied microbiology·2022
Same author

Renoprotective effects of prazosin on ischemia-reperfusion injury in rats.

Human & experimental toxicology·2021
Same author

Strategies for improving the emission performance of hybrid electric vehicles.

The Science of the total environment·2021
Same author

The irradiated fuel-burnup experiment of Tehran Research Reactor using nondestructive gamma-ray spectroscopy.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2020
Same author

Expression of coagulin A with low cytotoxic activity by Pediococcus pentosaceus ST65ACC isolated from raw milk cheese.

Journal of applied microbiology·2019
Same author

Polymyxins interaction to the human serum albumin: A thermodynamic and computational study.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2019

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.1K

Adenosine deaminase inhibition.

S Bagheri1, A A Saboury2, T Haertlé3

  • 1Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

International Journal of Biological Macromolecules
|September 15, 2019
PubMed
Summary

Adenosine deaminase (ADA) enzyme activity impacts inflammation and disease. While inhibitors show promise, clinical use is limited, with more in vivo research needed.

Keywords:
CancerCancer stagingDiabetesDisease gradingPurinergic signalingTherapeutic strategies

More Related Videos

Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells
05:01

Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells

Published on: April 30, 2023

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.1K
Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells
05:01

Extracellular Purine Metabolism: An HPLC-based Assay to Measure Adenosine Generation and Metabolism in Leukemic Cells

Published on: April 30, 2023

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.2K

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Adenosine deaminase (ADA) regulates purine metabolism and adenosine levels.
  • Adenosine signaling influences physiological functions and inflammation.
  • Elevated ADA activity is linked to various diseases.

Purpose of the Study:

  • To review data on increased ADA activity in diseases.
  • To discuss the impact of ADA inhibition across different conditions.
  • To assess the current state of ADA inhibitor development and clinical application.

Main Methods:

  • Literature review of studies on adenosine deaminase.
  • Analysis of in vitro and in vivo research on ADA activity and inhibition.
  • Compilation of data on the clinical course of diseases with altered ADA activity.

Main Results:

  • Adenosine deaminase activity increases in several diseases.
  • ADA inhibition shows significant effects on disease progression in various cases.
  • Many inhibitors have been developed, but clinical applications are limited.

Conclusions:

  • Adenosine deaminase plays a dual role in inflammation.
  • ADA inhibitors have therapeutic potential but face limited clinical use.
  • Further in vivo studies are crucial for expanding clinical applications of ADA inhibitors.